Open Beta
MetriLume

US marketsCNSY

SEC-sourced researchBeta

CNSY

CERENOME, INC.

Company comparison ↗

Data passport

CIK
0001095981
Exchange
Nasdaq
Business activity
Surgical & Medical Instruments & Apparatus · SIC 3841
Financial inputs
6/6
Filing date
Nov 16, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 5,824,000.0000 USD; December 2025: 5,213,000.0000 USD5.8M USD0 USD0December 2024December 2025
CNSY · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20245,824,000.0000Mar 12, 2026
December 20255,213,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20255,213,000.0000-22,386,000.0000-20,775,000.000016,325,000.000012,329,000.0000Mar 12, 2026
December 20245,824,000.0000-12,978,000.0000-10,554,000.00006,633,000.000015,582,000.0000Mar 12, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

33/100
Profitability0
Growth40
Balance sheet24
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$5.21MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Previous period revenueRevenues$5.82MJan 1, 2024 – Dec 31, 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$22.39MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$20.78MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Total assetsAssets$16.33MDec 31, 2025Mar 12, 202610-K
Total liabilitiesLiabilities$12.33MDec 31, 2025Mar 12, 202610-K

New filings

Explore methodology ↗